Inositol is a carbocyclic sugar involved in insulin signaling and serotonergic neurotransmission. Our research shows strong evidence for PCOS (improving ovulation, insulin resistance, and hormonal profiles) and moderate evidence for anxiety/panic disorder at high doses. Myo-inositol is the primary therapeutic form; D-chiro-inositol is used specifically for insulin resistance. The 40:1 ratio (myo:D-chiro) mirrors physiological proportions and is the best-studied combination.
Lithium depletes inositol; inositol supplementation may alter lithium's mood-stabilizing mechanism
Inositol has serotonergic activity; additive effects (mostly beneficial but monitor)
D-chiro-inositol improves insulin signaling; additive hypoglycemia risk
May deplete inositol; supplementation may be beneficial
Not Prohibited
Unfer V et al. Myo-inositol effects in women with PCOS: a meta-analysis.
Benjamin J et al. Double-blind, placebo-controlled, crossover trial of inositol in panic disorder.
D'Anna R et al. Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with family history.
Pundir J et al. Inositol treatment of anovulation in women with PCOS.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.